Dual-peptide research blend: CJC-1295 (No DAC) + Ipamorelin. Enables simultaneous GHRH/GHRP receptor co-activation for synergistic GH secretion research.
This combination formulation blends CJC-1295 (No DAC / Mod GRF 1-29), a stabilized GHRH analog, with Ipamorelin, a selective ghrelin receptor (GHSR-1a) agonist. The combination is designed to study the synergistic co-activation of two distinct somatotropic pathways: GHRH-mediated cAMP/PKA signaling and ghrelin-mediated phospholipase C activation. Both mechanisms converge on somatotrope GH granule release.
Each component HPLC >=99%; LC-MS confirmed; blending ratio verified gravimetrically. Full CoA for both components.
For Research Use Only. Not for human or veterinary use.
| Product Name | CJC1295+IPA |
| CAS Number | N/A (Combination) |
| Purity | ≥99% (each component) (by HPLC) |
| Molecular Weight | N/A |
| Molecular Formula | Dual-peptide blend |
| Appearance | White lyophilized powder (dual-component blend) |
| Storage | Store at -20C desiccated. Stable >=18 months. Reconstituted: use within 7 days at 2-8C. |
| Available Sizes | 10mg · Custom |
Store at -20C desiccated. Stable >=18 months. Reconstituted: use within 7 days at 2-8C.
24 months from manufacture when stored properly.
Cold-chain shipping with ice packs. Express delivery to 35+ countries.
Get premium research-grade peptides with complete documentation and worldwide delivery.
CJC1295+IPA · CAS N/A (Combination)
Quote request sent! We'll respond within 24 hours.
